Centrus Energy Corp. (LEU)
NYSEEnergyUraniumSnapshot 2026-09-04
$173.89+2.01%
Close 2026-09-04 · 1-day change
NYSEEnergyUraniumSnapshot 2026-09-04
Research Workspace
Put LEU beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Energy is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is slowing — up about 8% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 18%, softest on share dilution.
View QualityManagement screens weak on earnings delivery, margins, the balance sheet.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 66% in its worst 12-month stretch.
View RiskLEU's growth depends on expanding its uranium enrichment capabilities. Revenue grew 14% year over year, and the latest quarter beat expectations. It trades at 62× P/E versus a peer median of 23×, indicating the market prices in more growth than forecast. The risk lies in its fragile earnings quality, as reported profits are not well backed by cash. Peer multiples imply a price about 56% below where it trades (it looks expensive on this basis).
Trailing returns as of 2026-09-04. LEU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 19 analysts currently covering LEU (as of Sep 2026).
Based on 8 Wall Street analysts offering 12-month price targets for LEU in the last 4 months.
Continue this research
Compare LEU with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| LEU Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Coal & Consumable Fuels — fair value, gap to price, and forward P/E.
Compare the value case
Put LEU next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand uranium enrichment facility at Piketon and Oak Ridge
Centrifuge production supports facility expansion objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $173.89
The last 12 months of price, then the range of analyst 12-month targets from today’s $173.89.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
